Germany lifts Covid-19 prompted export ban for personal protective equipment

Eda Zhuleku

Today the German Government lifted the export ban for personal protective equipment, including protective masks, that had been instated by the general decree (Allgemeinverfügung) dated 4 March 2020 as amended on 12 March 2020. The purpose of the export ban (to both EU and non-EU countries) was to secure the supply of personal protective equipment in Read More

France takes concrete actions to ensure continued supply and good use of health products in the context of Covid-19

Jeanne Fabre

In the context of Covid-19, the French government took some immediate actions to ensure the supply and price limits of healthcare products (such as masks and hydro-alcoholic products) to healthcare professionals and health facilities in need and to ensure the good use of some medicinal products (see our previous blog post: “EU takes measures to Read More

China/US trade deal strengthens IP protection in China for pharmaceutical companies

David Shen

On 16 January 2020, China and the United States signed the Economic and Trade Agreement between the Government of the People’s Republic of China and the Government of the United States of America (the Phase One Trade Agreement). The Phase One Trade Agreement includes a chapter on intellectual property aimed at resolving a wide range Read More

New EU Directive on Whistleblower Protection will also apply to Life Sciences sector

Inge Vanderreken

On 7 October 2019, the Council of Ministers adopted the Directive on Whistleblower protection at the Justice and Home Affairs Council in Luxembourg. The Directive will introduce new EU-wide rules to protect whistleblowers who report breaches of EU law. “EU law breaches” include, amongst others, those relating to EU laws on product safety and compliance, Read More

China: NMPA Seeks Comments on Draft Regulations of Drug Registration, Manufacturing and Distribution

David Shen

On 30 September 2019, the Chinese National Medical Products Administration (the NMPA) published three sets of draft regulations seeking public comment. They are the Draft Drug Registration Regulations, the Draft Manufacturing Regulations and the Draft Drug Distribution Regulations. The Ministry of Justice further updated these Draft Regulations on 15 October 2019 and is seeking public Read More